An Open-Label, Two-Period, Single Sequence, Cross-Over, Drug-Drug Interaction Study to Evaluate the Effect of Multiple Dose Erythromycin on the Pharmacokinetics of GRC 17536 After a Single Dose in Healthy Male Subjects.

Trial Profile

An Open-Label, Two-Period, Single Sequence, Cross-Over, Drug-Drug Interaction Study to Evaluate the Effect of Multiple Dose Erythromycin on the Pharmacokinetics of GRC 17536 After a Single Dose in Healthy Male Subjects.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs GRC 17536 (Primary) ; Erythromycin
  • Indications Allergic asthma; Cough; Neuropathic pain
  • Focus Pharmacokinetics
  • Sponsors Glenmark Pharmaceuticals Ltd
  • Most Recent Events

    • 01 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top